Hepatitis aggravated and Joint pain

Summary:

Joint pain is found among people with Hepatitis aggravated, especially for people who are female, 50-59 old.

The study analyzes which people have Joint pain with Hepatitis aggravated. It is created by eHealthMe based on reports of 52 people who have Hepatitis aggravated from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hepatitis aggravated?

Hepatitis aggravated is found to be associated with 1,160 drugs and 433 conditions by eHealthMe. Check the latest studies of Hepatitis aggravated.

What is Joint pain?

Joint pain is found to be associated with 3,328 drugs and 5,212 conditions by eHealthMe. Check the latest studies of Joint pain.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 26, 2026

52 people who have Hepatitis Aggravated and Joint Pain are studied.

Would you have Joint pain when you have Hepatitis aggravated?

Gender of people who have Hepatitis Aggravated and experienced Joint Pain *:

  • female: 68.09 %
  • male: 31.91 %

Age of people who have Hepatitis Aggravated and experienced Joint Pain *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 5.71 %
  • 20-29: 8.57 %
  • 30-39: 5.71 %
  • 40-49: 20.0 %
  • 50-59: 40.0 %
  • 60+: 20.0 %

Common co-existing conditions for these people *:

  1. Depression: 9 people, 17.31%
  2. Hypersensitivity: 8 people, 15.38%
  3. Allergic Rhinitis: 8 people, 15.38%
  4. Diabetes: 8 people, 15.38%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 8 people, 15.38%
  6. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 8 people, 15.38%
  7. Migraine (headache): 8 people, 15.38%
  8. Muscle Spasms (muscle contraction): 8 people, 15.38%
  9. Oral Herpes (viral infection of mouth): 6 people, 11.54%
  10. Hepatitis C: 6 people, 11.54%

Common drugs taken by these people *:

  1. Methylprednisolone: 8 people, 15.38%
  2. Decadron: 8 people, 15.38%
  3. Wellbutrin: 8 people, 15.38%
  4. Estrogel: 8 people, 15.38%
  5. Dexilant: 8 people, 15.38%
  6. Omnaris: 8 people, 15.38%
  7. Benadryl: 8 people, 15.38%
  8. Myrbetriq: 8 people, 15.38%
  9. Ribavirin: 7 people, 13.46%
  10. Baclofen: 7 people, 13.46%

Common symptoms for these people *:

  1. Headache (pain in head): 19 people, 36.54%
  2. Pain: 18 people, 34.62%
  3. Nasopharyngitis (inflammation of the nasopharynx): 18 people, 34.62%
  4. Pain In Extremity: 16 people, 30.77%
  5. Fatigue (feeling of tiredness): 16 people, 30.77%
  6. Insomnia (sleeplessness): 14 people, 26.92%
  7. Nausea (feeling of having an urge to vomit): 13 people, 25.00%
  8. Gait Disturbance: 12 people, 23.08%
  9. Weight Decreased: 12 people, 23.08%
  10. Back Pain: 12 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Joint pain?

- Check whether Joint pain is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Joint pain:

All the conditions that are associated with Joint pain:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Joint pain and Hepatitis aggravated, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: